4//SEC Filing
Rizvi Qasim 4
Accession 0001179110-19-012840
CIK 0001730430other
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 4:54 PM ET
Size
5.5 KB
Accession
0001179110-19-012840
Insider Transaction Report
Form 4
Rizvi Qasim
Chief Commercial Officer
Transactions
- Award
Restricted Share Units
2019-12-12+7,337→ 7,337 total→ Class A Common Shares (7,337 underlying)
Footnotes (2)
- [F1]Each Restricted Share Unit represents a contingent right to receive one Class A Common Share of the Issuer.
- [F2]The Restricted Share Units will vest in a single installment on December 31, 2020, subject to the Reporting Person's continuous employment or service to the Issuer or any of its subsidiaries on the vesting date.
Documents
Issuer
Kiniksa Pharmaceuticals, Ltd.
CIK 0001730430
Entity typeother
Related Parties
1- filerCIK 0001794636
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 4:54 PM ET
- Size
- 5.5 KB